🔥Neoadjuvant short-course radiotherapy followed by camrelizumab + CTX vs long-course CRT followed by CTX in locally advanced rectal cancer #ESMO23
✅UNION phs-III, 231 pts
👉1° EP: pCR 39 vs 15.3%
👉Grade ≥ 3 TRAEs 29.2 vs 27.2%
😅Amazing waterfall blots.. safe & feasible, EFS & OS awaited
@myESMO@OncoAlert